Table 2.
Treatment | 0 h | 2 h | 4 h | 6 h |
---|---|---|---|---|
Blank control | 69.42 ± 0.49 | 71.53 ± 0.51 | 71.44 ± 0.62 | 70.85 ± 0.15 |
Negative control | 68.96 ± 0.38 | 462.43 ± 0.80# | 673.41 ± 0.48# | 366.61 ± 0.55# |
Cefoperazone/sulbactam | 69.72 ± 0.45 | 309.14 ± 0.27*,# | 462.53 ± 0.25*,# | 222.81 ± 0.73*,# |
Dexamethasome | 69.11 ± 0.32 | 455.95 ± 0.38*,# | 655.64 ± 0.42*,# | 245.01 ± 0.17*,# |
B-IgY | 70.44 ± 0.96 | 189.42 ± 0.42*,# | 196.47 ± 0.46*,# | 70.31 ± 0.28* |
C-IgY | 71.48 ± 0.39 | 228.78 ± 0.75*,# | 248.16 ± 0.19*,# | 72.81 ± 0.57* |
Data are presented as means ± SD (n = 3).
p < 0.05 compared with the blank control at the same time.
p < 0.05 compared with the negative control at the same time.